Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Starch Medical, a medical device company, has launched its advanced PerClot laparoscopic hemostat in the EU and other major international markets.
Subscribe to our email newsletter
PerClot Laparoscopic, a delivery configuration within the PerClot polysaccharide hemostatic system, was awarded CE approval in 2008. Perclot laparoscopic is a hemostatic system designed for applications in minimally invasive surgical procedures.
According to Starch Medical, the PerClot laparoscopic system contains a unique instrument for precise delivery of absorbable modified polymer (AMP) particles through the laparoscope to the bleeding site.
The delivery instrument is easily attached to the PerClot bellows dispenser and enables hemostat delivery under direct vision to the wound site for the control of capillary, venous and arterial bleeding. The PerClot laparoscopic instrument can be employed in the working channel of a standard laparoscope for the delivery of AMP particles, the company said.
David Lang, president of Starch Medical, said: “The clinical introduction of PerClot laparoscopic and its proprietary, integrated AMP technology represents a unique advancement in hemostatic delivery. The company is pleased to offer surgeons a delivery option which will enhance the control of bleeding in the expanding practice of minimally invasive surgery.”